Genetic testing of breast tumour tissue can predict whether there is any likely benefit to enduring chemotherapy. Medical experts say that for some women diagnosed with early breast cancer, chemotherapy may be un-necessary.
Specialised Therapeutics is disapppointed by the recent decision not to fund the Oncotype DX Breast Cancer Assay.
The test is funded in most other developed countries including the US, UK, Canada and throughout Europe, and has been shown to identify which patients might benefit from chemotherapy.
Melbourne bookshop owner Deb Force underwent testing and managed to avoid chemotherapy.
Here is Deb's story. To view, please click on the thumbnail below.